Nextpoint Therapeutics, Inc.

Nextpoint Therapeutics, Inc. company information, Employees & Contact Information

NextPoint is launching a new world of precision therapeutics through its leading scientific work on the novel B7-H7/HHLA2 axis. Our team of proven drug developers is advancing an antibody-drug conjugate with our proprietary linker technology, a T-cell engager with wide therapeutic window, and a multi-functional checkpoint inhibitor. Our innovative approach integrates foundational science with a defined clinical biomarker to identify the right patient population for each B7-H7-directed modality, so that we can deliver first-in-class therapies to a broad range of cancer patients with B7-H7 upregulation including those who do not benefit from currently approved therapies such as PD-1/L1 inhibitors.
Looking for a particular Nextpoint Therapeutics, Inc. employee's phone or email?

Nextpoint Therapeutics, Inc. Questions

News

NextPoint Therapeutics to Showcase Pioneering Preclinical Data on NPX125, a Novel B7-H7 Targeted Antibody-Drug Conjugate (ADC) at AACR Annual Meeting 2025 - Yahoo Finance

NextPoint Therapeutics to Showcase Pioneering Preclinical Data on NPX125, a Novel B7-H7 Targeted Antibody-Drug Conjugate (ADC) at AACR Annual Meeting 2025 Yahoo Finance

NextPoint Therapeutics Chief Executive Officer Ivan Cheung Named to the 2024 TIME100 Health List - citybiz

NextPoint Therapeutics Chief Executive Officer Ivan Cheung Named to the 2024 TIME100 Health List citybiz

NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital Management - Business Wire

NextPoint Therapeutics Announces Closing of Series B Financing Extension Led by Catalio Capital Management Business Wire

NextPoint Therapeutics Appoints Ivan Cheung as Chief Executive Officer - citybiz

NextPoint Therapeutics Appoints Ivan Cheung as Chief Executive Officer citybiz

NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer - Business Wire

NextPoint Therapeutics Appoints Leena Gandhi, MD, PhD, as Chief Medical Officer Business Wire

Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors - citybiz

Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors citybiz

NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs - Business Wire

NextPoint Therapeutics Announces $80 Million Series B Financing co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs Business Wire

Top Nextpoint Therapeutics, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant